HomeComparePEYE vs ORCC

PEYE vs ORCC: Dividend Comparison 2026

PEYE yields 102.56% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEYE wins by $4.30M in total portfolio value
10 years
PEYE
PEYE
● Live price
102.56%
Share price
$1.95
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.32M
Annual income
$1,481,817.76
Full PEYE calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — PEYE vs ORCC

📍 PEYE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPEYEORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PEYE + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PEYE pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PEYE
Annual income on $10K today (after 15% tax)
$8,717.95/yr
After 10yr DRIP, annual income (after tax)
$1,259,545.10/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, PEYE beats the other by $1,259,544.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PEYE + ORCC for your $10,000?

PEYE: 50%ORCC: 50%
100% ORCC50/50100% PEYE
Portfolio after 10yr
$2.17M
Annual income
$740,909.40/yr
Blended yield
34.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

PEYE
No analyst data
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PEYE buys
0
ORCC buys
0
No recent congressional trades found for PEYE or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPEYEORCC
Forward yield102.56%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$4.32M$21.4K
Annual income after 10y$1,481,817.76$1.04
Total dividends collected$3.87M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: PEYE vs ORCC ($10,000, DRIP)

YearPEYE PortfolioPEYE Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$20,956$10,256.41$11,190$489.61+$9.8KPEYE
2$42,511$20,087.62$12,229$256.01+$30.3KPEYE
3$83,570$38,082.81$13,216$130.74+$70.4KPEYE
4$159,386$69,966.82$14,207$66.02+$145.2KPEYE
5$295,256$124,712.82$15,234$33.17+$280.0KPEYE
6$531,835$215,911.30$16,317$16.62+$515.5KPEYE
7$932,535$363,471.12$17,468$8.32+$915.1KPEYE
8$1,593,439$595,626.55$18,695$4.16+$1.57MPEYE
9$2,656,155$951,175.34$20,006$2.08+$2.64MPEYE
10$4,323,904$1,481,817.76$21,407$1.04+$4.30MPEYE

PEYE vs ORCC: Complete Analysis 2026

PEYEStock

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

Full PEYE Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this PEYE vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PEYE vs SCHDPEYE vs JEPIPEYE vs OPEYE vs KOPEYE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.